These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6769026)
1. [Chronic myelocytic leukemia. Therapy in lymphadenosis (CLL)]. Huhn D MMW Munch Med Wochenschr; 1980 Apr; 122(14):501-3. PubMed ID: 6769026 [No Abstract] [Full Text] [Related]
2. [Correlations between lymphocyte subpopulation and stage of disease in chronic lymphatic leukemia of Rai]. Heilmann E; Nordiek R Haematologia (Budap); 1977; 11(3-4):289-95. PubMed ID: 311309 [TBL] [Abstract][Full Text] [Related]
3. [When do we have to treat chronic leukemia?]. Maurice PA Schweiz Med Wochenschr; 1978 Aug; 108(32):1238-41. PubMed ID: 276923 [TBL] [Abstract][Full Text] [Related]
4. Notes on morphologically less usual forms of chronic lymphadenosis. Hermanský F; Janele J; Smetana K Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 90(1):31-9. PubMed ID: 4176388 [No Abstract] [Full Text] [Related]
5. [Effect of extracorporeal blood irradiation and cytostatic agents on B- and T-lymphocytes in patients with chronic lymphadenosis]. Heilmann E; Nordiek R; Wannenmacher M; Vogel M Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1105-7. PubMed ID: 306164 [No Abstract] [Full Text] [Related]
6. Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs. Kopeć J; Sitarska E; Leszko B Arch Immunol Ther Exp (Warsz); 1983; 31(4):481-7. PubMed ID: 6670918 [TBL] [Abstract][Full Text] [Related]
7. Proceedings: The chronic leukemias: current therapeutic concepts. Canellos GP; De Vita VT; Schein P; Chabner B; Young RC Proc Natl Cancer Conf; 1972; 7():351-7. PubMed ID: 4520052 [No Abstract] [Full Text] [Related]
8. The dynamics of morphological and cytoenzymatic changes in peripheral blood lymphocyte lysosomes in patients with chronic lymphocytic leukemia during treatment. Grabarczyk M; Sitarska E; Leszko B Arch Immunol Ther Exp (Warsz); 1983; 31(4):475-80. PubMed ID: 6670917 [TBL] [Abstract][Full Text] [Related]
13. [Different response of superficial and deep lymph nodes to drug therapy in malignant lymphoreticulopathy]. Morgenfeld MC; Helft F; Bomchil G Therapeutique; 1969 Mar; 45(3):294-300. PubMed ID: 4989245 [No Abstract] [Full Text] [Related]
14. [Chlorambucil therapy for chronic lymphocytic leukemia]. Ota H; Morita A; Yasuma A Rinsho Ketsueki; 1973 Jan; 14(1):94-101. PubMed ID: 4734793 [No Abstract] [Full Text] [Related]
15. [The treatment of chronic lymphatic leukemia]. Obrecht P; Heilmeyer L Munch Med Wochenschr; 1966 Sep; 108(35):1717-20. PubMed ID: 4173541 [No Abstract] [Full Text] [Related]
16. Management of CLL patients after chlorambucil therapy. Special value of a second RAI staging. Michallet M; Sotto JJ; Moulin JJ; Arvieux J; Hollard D Eur J Cancer (1965); 1980 Apr; 16(4):511-7. PubMed ID: 7398721 [No Abstract] [Full Text] [Related]
17. [Treatment of chronic leukemias]. Theml H; Kaboth W Munch Med Wochenschr; 1973 May; 115(18):843-51. PubMed ID: 4517730 [No Abstract] [Full Text] [Related]
18. [Studies on cell-mediated immunity in patients with chronic lymphatic leukemia]. Fuchs R; Mey U Z Gesamte Inn Med; 1977 Oct; 32(19):495-9. PubMed ID: 595723 [TBL] [Abstract][Full Text] [Related]
19. [The role of deoxyribonuclease in the treatment of chronic lymphocytic leukemia]. Esposito S; Taylor LA Haematologica; 1972; 57(12):803-14. PubMed ID: 4219201 [No Abstract] [Full Text] [Related]
20. Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation. Shustik C; Mick R; Silver R; Sawitsky A; Rai K; Shapiro L Hematol Oncol; 1988; 6(1):7-12. PubMed ID: 3277904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]